Page last updated: 2024-11-03

pyridinolcarbamate and Cerebral Arteriosclerosis

pyridinolcarbamate has been researched along with Cerebral Arteriosclerosis in 3 studies

Pyridinolcarbamate: A drug that has been given by mouth in the treatment of atherosclerosis and other vascular disorders, hyperlipidemias, and thrombo-embolic disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1408)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sobczyk, W1
Kruszewska, J1
Szymchel, J1
Kuz'ko, NV1
Shimamoto, T1

Reviews

1 review available for pyridinolcarbamate and Cerebral Arteriosclerosis

ArticleYear
New concept on atherogenesis and treatment of atherosclerotic diseases.
    Japanese heart journal, 1972, Volume: 13, Issue:6

    Topics: Adenosine Diphosphate; Animals; Aorta; Arteriosclerosis; Blood Platelets; Blood Proteins; Blood Vess

1972

Trials

1 trial available for pyridinolcarbamate and Cerebral Arteriosclerosis

ArticleYear
[Comparison of the effectiveness of anginin and stugeron treatment of cerebral arteriosclerosis].
    Neurologia i neurochirurgia polska, 1980, Volume: 14, Issue:2

    Topics: Adult; Aged; Carbamates; Cerebrovascular Circulation; Cinnarizine; Clinical Trials as Topic; Double-

1980

Other Studies

1 other study available for pyridinolcarbamate and Cerebral Arteriosclerosis

ArticleYear
[Pyridinolcarbamate treatment of ischemic heart disease].
    Vrachebnoe delo, 1976, Issue:1

    Topics: Aged; Arteriosclerosis; Carbamates; Coronary Disease; Humans; Intracranial Arteriosclerosis; Middle

1976